| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
RANBP3 |
RANBP3: Ran-binding protein 3 |
2.43 |
Evidence |
|
| CCNE2 |
CCNE2: G1/S-specific cyclin-E2 |
RB1 |
RB1: Retinoblastoma-associated protein |
2.43 |
Evidence |
|
| DDX58 |
DDX58: Probable ATP-dependent RNA helicase DDX58 |
TRIM4 |
TRIM4, RNF87: Tripartite motif-containing protein 4 |
2.43 |
Evidence |
|
| LSM8 |
LSM8: U6 snRNA-associated Sm-like protein LSm8 |
FLJ12671 |
ISG20L2, HSD38, HSD-38: Interferon-stimulated 20 kDa exonuclease-like 2 |
2.43 |
Evidence |
|
| LSM8 |
LSM8: U6 snRNA-associated Sm-like protein LSm8 |
TLE6 |
TLE6: Transducin-like enhancer protein 6 |
2.43 |
Evidence |
|
| LSM8 |
LSM8: U6 snRNA-associated Sm-like protein LSm8 |
RFWD2 |
RFWD2, COP1, RNF200: E3 ubiquitin-protein ligase RFWD2 |
2.43 |
Evidence |
|
| LSM8 |
LSM8: U6 snRNA-associated Sm-like protein LSm8 |
DDX53 |
DDX53, CAGE: Probable ATP-dependent RNA helicase DDX53 |
2.43 |
Evidence |
|
| SRA1 |
APBB3, FE65L2: Amyloid beta A4 precursor protein-binding family B member 3 |
STAT3 |
|
2.43 |
Evidence |
|
| WISP1 |
WISP1, CCN4: WNT1-inducible-signaling pathway protein 1 precursor |
APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
2.43 |
Evidence |
|
| IPO7 |
IPO7: Uncharacterized protein IPO7 |
RANBP3 |
RANBP3: Ran-binding protein 3 |
2.43 |
Evidence |
|
| KCNH1 |
KCNH1, EAG, EAG1: Potassium voltage-gated channel subfamily H member 1 |
PRKAR1B |
PRKAR1B: cAMP-dependent protein kinase type I-beta regulatory subunit |
2.43 |
Evidence |
|
| SFRS15 |
SFRS15, KIAA1172: Splicing factor, arginine/serine-rich 15 |
ACF |
ACF, ASP: APOBEC1 complementation factor |
2.43 |
Evidence |
|
| PIAS1 |
PIAS1, DDXBP1: E3 SUMO-protein ligase PIAS1 |
THRA |
THRA, ERBA1, NR1A1, THRA1, THRA2: Thyroid hormone receptor alpha |
2.43 |
Evidence |
|
| RPS6KA4 |
RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 |
DUSP10 |
DUSP10, MKP5: Dual specificity protein phosphatase 10 |
2.43 |
Evidence |
|
| LEFTY1 |
LEFTY1, LEFTB, UNQ278/PRO317, LEFTYB: Left-right determination factor 1 precurso |
GDF11 |
GDF11, BMP11: Growth/differentiation factor 11 precursor |
2.43 |
Evidence |
|
| CRLF1 |
CRLF1, ZCYTOR5, UNQ288/PRO327: Cytokine receptor-like factor 1 precursor |
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
2.43 |
Evidence |
|
| CRLF1 |
CRLF1, ZCYTOR5, UNQ288/PRO327: Cytokine receptor-like factor 1 precursor |
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
2.43 |
Evidence |
|
| CDH16 |
CDH16, UNQ695/PRO1340: Cadherin-16 precursor |
PCDH17 |
PCDH17: Uncharacterized protein PCDH17 |
2.43 |
Evidence |
|
| CDH16 |
CDH16, UNQ695/PRO1340: Cadherin-16 precursor |
PCDHGB6 |
PCDHGB6: Protocadherin gamma B6 precursor |
2.43 |
Evidence |
|
| CDH16 |
CDH16, UNQ695/PRO1340: Cadherin-16 precursor |
CDH24 |
CDH24, CDH11L, UNQ2834/PRO34009: Cadherin-24 precursor |
2.43 |
Evidence |
|
| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
ELMO1 |
IPI00219532 |
2.43 |
Evidence |
|
| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
DOK3 |
IPI00156649 |
2.43 |
Evidence |
|
| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
NEDD9 |
NEDD9, CASL: Enhancer of filamentation 1 |
2.43 |
Evidence |
|
| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
DYRK1A |
DYRK1A, DYRK, MNB, MNBH: Dual specificity tyrosine-phosphorylation-regulated kin |
2.43 |
Evidence |
|
| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
2.43 |
Evidence |
|